251 related articles for article (PubMed ID: 16923540)
1. Complement regulatory proteins and autoimmunity.
Song WC
Autoimmunity; 2006 Aug; 39(5):403-10. PubMed ID: 16923540
[TBL] [Abstract][Full Text] [Related]
2. Complement regulatory proteins and autoimmunity.
Kawano M
Arch Immunol Ther Exp (Warsz); 2000; 48(5):367-72. PubMed ID: 11140463
[TBL] [Abstract][Full Text] [Related]
3. Complement deficiencies in humans and animals: links to autoimmunity.
Lewis MJ; Botto M
Autoimmunity; 2006 Aug; 39(5):367-78. PubMed ID: 16923536
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus.
Cook HT; Botto M
Nat Clin Pract Rheumatol; 2006 Jun; 2(6):330-7. PubMed ID: 16932712
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity to protective molecules: is it the perpetuum mobile (vicious cycle) of autoimmune rheumatic diseases?
Kravitz MS; Shoenfeld Y
Nat Clin Pract Rheumatol; 2006 Sep; 2(9):481-90. PubMed ID: 16951703
[TBL] [Abstract][Full Text] [Related]
6. The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias.
Ruiz-Argüelles A; Llorente L
Autoimmun Rev; 2007 Jan; 6(3):155-61. PubMed ID: 17289551
[TBL] [Abstract][Full Text] [Related]
7. Fc receptors and their interaction with complement in autoimmunity.
Schmidt RE; Gessner JE
Immunol Lett; 2005 Aug; 100(1):56-67. PubMed ID: 16125792
[TBL] [Abstract][Full Text] [Related]
8. Membrane complement regulatory proteins.
Kim DD; Song WC
Clin Immunol; 2006; 118(2-3):127-36. PubMed ID: 16338172
[TBL] [Abstract][Full Text] [Related]
9. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59.
Clayton A; Harris CL; Court J; Mason MD; Morgan BP
Eur J Immunol; 2003 Feb; 33(2):522-31. PubMed ID: 12645951
[TBL] [Abstract][Full Text] [Related]
10. Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-alpha,beta on monocytes from patients with warm autoimmune hemolytic anemia.
Barros MM; Yamamoto M; Figueiredo MS; Cançado R; Kimura EY; Langhi DM; Chiattone CS; Bordin JO
Transfusion; 2009 Jan; 49(1):154-60. PubMed ID: 18954403
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of the complement regulatory proteins human DAF and CD59 with an IRES-mediated dicistronic mammalian vector enhances their cell protective effects.
Xu L; Shao H; Wu W; Cao Z; Zhao Z; Liu H; Jiang D; Mao X; Li W
Int J Mol Med; 2005 Sep; 16(3):409-14. PubMed ID: 16077947
[TBL] [Abstract][Full Text] [Related]
12. How can human DAF and HRF20 prevent HAR in transgenic mice?
Koike C; Isobe K; Nakashima I; Okada H; Hayashi S; Yokoyama I; Takagi H
Transplant Proc; 1996 Apr; 28(2):599-600. PubMed ID: 8623294
[No Abstract] [Full Text] [Related]
13. The role of CR2 in autoimmunity.
Isaák A; Prechl J; Gergely J; Erdei A
Autoimmunity; 2006 Aug; 39(5):357-66. PubMed ID: 16923535
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59.
Qu Z; Liang X; Liu Y; Du J; Liu S; Sun W
Mol Immunol; 2009 Dec; 47(2-3):283-9. PubMed ID: 19804910
[TBL] [Abstract][Full Text] [Related]
15. The complement system in systemic autoimmune disease.
Chen M; Daha MR; Kallenberg CG
J Autoimmun; 2010 May; 34(3):J276-86. PubMed ID: 20005073
[TBL] [Abstract][Full Text] [Related]
16. Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.
Ziller F; Macor P; Bulla R; Sblattero D; Marzari R; Tedesco F
Eur J Immunol; 2005 Jul; 35(7):2175-83. PubMed ID: 15971270
[TBL] [Abstract][Full Text] [Related]
17. Complement deficiencies and systemic lupus erythematosus.
Truedsson L; Bengtsson AA; Sturfelt G
Autoimmunity; 2007 Dec; 40(8):560-6. PubMed ID: 18075790
[TBL] [Abstract][Full Text] [Related]
18. Contribution of the innate immune system to autoimmune myocarditis: a role for complement.
Kaya Z; Afanasyeva M; Wang Y; Dohmen KM; Schlichting J; Tretter T; Fairweather D; Holers VM; Rose NR
Nat Immunol; 2001 Aug; 2(8):739-45. PubMed ID: 11477411
[TBL] [Abstract][Full Text] [Related]
19. The alternative pathway of complement in disease: opportunities for therapeutic targeting.
Holers VM; Thurman JM
Mol Immunol; 2004 Jun; 41(2-3):147-52. PubMed ID: 15159060
[TBL] [Abstract][Full Text] [Related]
20. [Role of membrane molecules in complement system].
Okada N
Rinsho Byori; 1991 Sep; Suppl 91():129-39. PubMed ID: 1721938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
